Literature DB >> 28589300

Extracorporeal devices for treatment of refractory pruritus in cholestatic liver disease.

Roger Williams1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28589300     DOI： 10.1007/s12072-017-9802-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  12 in total

1.  'Out-patient' albumin dialysis for cholestatic patients with intractable pruritus.

Authors:  P Leckie; G Tritto; R Mookerjee; N Davies; D Jones; R Jalan
Journal:  Aliment Pharmacol Ther       Date:  2012-01-20       Impact factor: 8.171

2.  Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.

Authors:  Andreas E Kremer; Remco van Dijk; Pamela Leckie; Frank G Schaap; Edith M M Kuiper; Thomas Mettang; Katrin S Reiners; Ulrike Raap; Henk R van Buuren; Karel J van Erpecum; Nathan A Davies; Christian Rust; Andreas Engert; Rajiv Jalan; Ronald P J Oude Elferink; Ulrich Beuers
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

3.  Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

Authors:  B G Gazzard; M J Weston; I M Murray-Lyon; H Flax; C O Record; R Williams; B Portmann; P G Langley; E H Dunlop; P J Mellon; M B Ward
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

4.  Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers.

Authors:  Albert Parés; Manuel Herrera; Juan Avilés; Miquel Sanz; Antoni Mas
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

5.  Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch.

Authors:  Marcin Krawczyk; Roman Liebe; Michał Wasilewicz; Ewa Wunsch; Joanna Raszeja-Wyszomirska; Piotr Milkiewicz
Journal:  Liver Int       Date:  2016-11-17       Impact factor: 5.828

6.  The molecular mechanism of cholestatic pruritus.

Authors:  Ronald P J Oude Elferink; Andreas E Kremer; Job J W W Martens; Ulrich H Beuers
Journal:  Dig Dis       Date:  2011-06-17       Impact factor: 2.404

7.  Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease.

Authors:  Wonngarm Kittanamongkolchai; Ziad M El-Zoghby; J Eileen Hay; Russell H Wiesner; Patrick S Kamath; Nicholas F LaRusso; Kymberly D Watt; Carl H Cramer; Nelson Leung
Journal:  Hepatol Int       Date:  2016-12-08       Impact factor: 6.047

Review 8.  Pathogenesis and Management of Pruritus in PBC and PSC.

Authors:  Andreas E Kremer; Barbara Namer; Ruth Bolier; Michael J Fischer; Ronald P Oude Elferink; Ulrich Beuers
Journal:  Dig Dis       Date:  2015-12-07       Impact factor: 2.404

9.  Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads.

Authors:  B H Lauterburg; H F Taswell; A A Pineda; E R Dickson; E A Burgstaler; G L Carlson
Journal:  Lancet       Date:  1980-07-12       Impact factor: 79.321

10.  Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.

Authors:  Vinod S Hegade; Stuart F W Kendrick; Robert L Dobbins; Sam R Miller; Douglas Thompson; Duncan Richards; James Storey; George E Dukes; Margaret Corrigan; Ronald P J Oude Elferink; Ulrich Beuers; Gideon M Hirschfield; David E Jones
Journal:  Lancet       Date:  2017-02-08       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.